Kraj: Unia Europejska
Język: angielski
Źródło: EMA (European Medicines Agency)
sugammadex
Merck Sharp & Dohme B.V.
V03AB35
sugammadex
All other therapeutic products
Neuromuscular Blockade
Reversal of neuromuscular blockade induced by rocuronium or vecuronium.For the peadiatric population: sugammadex is only recommended for routine reversal of rocuronium-induced blockade in children and adolescents.
Revision: 22
Authorised
2008-07-25
27 B. PACKAGE LEAFLET 28 PACKAGE LEAFLET : INFORMATION FOR THE USER BRIDION 100 MG/ML SOLUT ION FOR INJECTI ON sugammadex READ ALL O F THIS LEAFLE T CAREFULLY BEFORE YO U ARE GI VEN THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leafl et. You may need to read it agai n. • If y ou have further questi ons, ask your anaesthetist or doctor. • If you get any side effects, ta lk to your an aesthetist or other d octor. T his includes any possible side effects not listed i n this leaflet. See section 4. WHAT IS I N THIS LEAFLET 1. What Bridion is and what it is use d for 2. What you need to kno w before Bridion is given 3. How Bridion is given 4. Possible side effects 5. How to store Bridion 6. Conten ts of the pack and other information 1. W HAT BRIDION IS AND WHAT IT IS USED FOR WHAT BRIDION IS Bridion contains the active substance sugammadex. Bridion is con s idered to be a Selective Relaxant Binding Agent since it only work s with specific m uscle rel axants, rocuronium bromid e or vecuronium bromide. WHAT BR IDION IS USED FOR When you have some ty pes of operation s, you r muscles must be completely relaxed. This m akes it easier for the su rgeon to do t he operation. For thi s, the g eneral anaestheti c you are given includes medicines to make your muscles relax. Thes e are called muscle relaxants , and exam ples include rocuroniu m bromide and vecuronium brom ide. Because th e se medicines al so make y our breathing muscles relax, you n eed help to breathe (arti ficial ve ntilation) during and aft er y our operation until you can b reathe on your own again. Bridion is us ed to speed up the rec overy of your muscles after a n operation to a llow you to bre athe on y our own again earlier. It does thi s by com bining with the r ocuronium bromide or vecuronium bromid e in your body. It can be use d in adults whenever rocuronium bromide or vecuronium bromide is used and in children and adolescents (ag e d 2 to 17 years ) when ro curonium brom ide is used for a moderate le vel of rel Przeczytaj cały dokument
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE MEDICINAL PRODUCT Bridion 100 mg/mL solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 mL contains sugammadex sodium equivalent to 100 mg sugammadex. Each vial of 2 mL contains sugammadex sodium equivalent to 200 mg sugammadex. Each vial of 5 mL contains sugammadex sodium equivalent to 500 mg sugammadex. Excipient(s) with known effect Contains up to 9.7 mg/mL sodium (see section 4.4). For the full lis t of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection (injection). Clear and colourless to slightly yellow solution. The pH is between 7 and 8 and osmolality is between 300 and 500 mOsm/kg. 4. CLINICAL PARTICULARS 4.1 THERAP EUTIC INDICATIONS Reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. For the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced bl ockade in chil dren and adolescents aged 2 to 17 years. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Sugammadex should only be administered by, or under the supervision of an anaesthetist. The use of an appropriate neuromuscular monitoring techniq ue is recommen ded to monitor the recovery of ne uromuscular blockade (see section 4.4). The recommended dose of sugammadex depends on the level of neuromuscular blockade to be reversed. The recommended dose does not depend on the anaesthetic regimen. Sugam madex can be u sed to reverse different levels o f rocuronium or vecuronium induced neuromuscular blockade: Adults Routine reversal: A dose of 4 mg/kg sugammadex is recommended if recovery has reached at least 1 -2 post-tetanic counts (PTC) following rocuro nium or vecuro nium induced blockade. M edian tim e to recovery of the T 4 /T 1 ratio to 0.9 is around 3 minutes (see section 5.1). A dose of 2 mg/kg sugammadex is recommended, if spontaneous recovery has occurred up to at least the reappearance of T 2 following rocuronium or vecuronium induced block ade. Median time to recovery of Przeczytaj cały dokument